Burkitt’s Lymphoma

  • Trial ID: 18-443 | NCT03793140
  • Last Updated: 21 May, 2020

Clinical Trial 18-443: Patients with Burkitt’s Lymphoma/Leukemia or High-Grade B-cell Lymphoma

To determine the overall response rate of CPI-613® in patients with relapsed or refractory Burkitt’s Lymphoma/Leukemia and double hit/ diffuse large B cell lymphoma analyzed as two separate cohorts.

  • 4 Sites

For Patients

Get information about indications and participating in clinical trials that match your diagnoses.

More Info

For Physicians

Learn about treatments and read the latest news and resources for health professionals.

More Info

Have questions? Live support is available 24/7 - Call (609) 409 7050 or Email Us